• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年型胱氨酸病的自然史。

Natural history of adolescent-onset cystinosis.

机构信息

Department of Pediatrics, Alberta Children's Hospital, 2888 Shaganappi Trail, NW, Calgary, AB, T3B 6A8, Canada.

出版信息

Pediatr Nephrol. 2011 Aug;26(8):1335-7. doi: 10.1007/s00467-011-1904-z. Epub 2011 May 8.

DOI:10.1007/s00467-011-1904-z
PMID:21553323
Abstract

Cystinosis is a rare autosomal recessive disease caused by mutations of the CTNS gene in which cystine accumulates throughout the body as a result of a defective efflux of cystine from lysosomes. Three phenotypic forms have been described according to the age of onset and the severity of the clinical symptoms: infantile, intermediate, and ocular non-nephropathic cystinosis. Here we report the natural history of cystinosis in a 55-year-old man with intermediate nephropathic cystinosis diagnosed at 9 years of age. Although tubulopathy was unnoticed in the early years, he required transplantation at age 16. Sequencing analysis of all the CTNS exons revealed that the proband is homozygous for a 21-bp in-frame deletion in exon 5 (c. 198_218del21), resulting in an in-frame deletion of 7 amino acids from the N-terminal domain of the cystinosin protein. Our patient has had relatively mild extra-renal disease despite lack of early cysteamine therapy. He has been able to attend university and pursue a professional career into the 6th decade.

摘要

胱氨酸贮积症是一种罕见的常染色体隐性遗传病,由 CTNS 基因突变引起,由于溶酶体中胱氨酸的排出功能缺陷,胱氨酸会在全身蓄积。根据发病年龄和临床症状的严重程度,可将其分为三种表型:婴儿型、中间型和眼-非肾病型胱氨酸贮积症。本研究报道了 1 例 9 岁时被诊断为中间型肾病型胱氨酸贮积症的 55 岁男性患者的自然病史。尽管在早期并未发现肾小管病变,但他在 16 岁时需要进行移植。对所有 CTNS 外显子进行测序分析显示,该先证者为第 5 外显子(c.198_218del21)21 个碱基对的框内缺失纯合子,导致胱氨酸蛋白酶 N 端结构域的 7 个氨基酸缺失。尽管未进行早期半胱氨酸治疗,我们的患者仍具有相对较轻的肾外疾病。他能够上大学,并在 60 多岁时继续从事专业职业。

相似文献

1
Natural history of adolescent-onset cystinosis.青少年型胱氨酸病的自然史。
Pediatr Nephrol. 2011 Aug;26(8):1335-7. doi: 10.1007/s00467-011-1904-z. Epub 2011 May 8.
2
CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.CTNS mRNA 分子分析显示一例婴儿型胱氨酸贮积症患儿的新突变:病例报告。
BMC Nephrol. 2019 Oct 31;20(1):400. doi: 10.1186/s12882-019-1589-2.
3
An Indian boy with nephropathic cystinosis: a case report and molecular analysis of CTNS mutation.一名患有肾病型胱氨酸病的印度男孩:病例报告及CTNS基因突变的分子分析
Genet Test Mol Biomarkers. 2009 Aug;13(4):435-8. doi: 10.1089/gtmb.2008.0156.
4
Molecular analysis of the CTNS gene in Jordanian families with nephropathic cystinosis.对患有肾病型胱氨酸病的约旦家庭中CTNS基因的分子分析。
Nefrologia. 2015 Nov-Dec;35(6):547-53. doi: 10.1016/j.nefro.2015.09.009. Epub 2015 Nov 10.
5
[From gene to disease: cystinosis].从基因到疾病:胱氨酸贮积症
Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8.
6
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.胱氨酸病的表型严重程度因CTNS基因突变而异:对胱氨酸转运蛋白模型的预测影响。
Hum Mol Genet. 1999 Dec;8(13):2507-14. doi: 10.1093/hmg/8.13.2507.
7
Nephropathic cystinosis: an update on genetic conditioning.遗传性胱氨酸病:遗传修饰的最新进展。
Pediatr Nephrol. 2021 Jun;36(6):1347-1352. doi: 10.1007/s00467-020-04638-9. Epub 2020 Jun 20.
8
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.肾性胱氨酸病的争议和研究议程:“改善全球肾脏病预后组织”(KDIGO)争议会议的结论。
Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.
9
CTNS mutations in an American-based population of cystinosis patients.美国胱氨酸病患者群体中的CTNS基因突变。
Am J Hum Genet. 1998 Nov;63(5):1352-62. doi: 10.1086/302118.
10
Cystinosis and two rare mutations in CTNS gene: two case reports.胱氨酸病及 CTNS 基因两种罕见突变:两例报告。
J Med Case Rep. 2022 May 6;16(1):181. doi: 10.1186/s13256-022-03379-7.

引用本文的文献

1
Residual Cystine Transport Activity for Specific Infantile and Juvenile Mutations in a PTEC-Based Addback Model.基于 PTEC 的添加模型中特定婴儿期和青少年突变的胱氨酸残留转运活性。
Cells. 2024 Apr 6;13(7):646. doi: 10.3390/cells13070646.
2
ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine.胱氨酸病发病机制中的内质网相关降解和精准医学的前景。
J Clin Invest. 2023 Oct 2;133(19):e169551. doi: 10.1172/JCI169551.
3
Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability.

本文引用的文献

1
Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.迟发性肾病型胱氨酸病:临床表现、预后及基因分型
Clin J Am Soc Nephrol. 2008 Jan;3(1):27-35. doi: 10.2215/CJN.01740407.
2
Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.成人肾性胱氨酸病:自然病程及口服半胱胺治疗的效果
Ann Intern Med. 2007 Aug 21;147(4):242-50. doi: 10.7326/0003-4819-147-4-200708210-00006.
3
Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
与萨格奈-圣让地区的创始人效应相关的遗传负担说明了遗传筛查测试可用性的重要性。
J Med Genet. 2021 Oct;58(10):653-665. doi: 10.1136/jmedgenet-2021-107809. Epub 2021 Apr 28.
4
The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.新型氨基糖苷类药物 ELX-02 可实现 CTNSW138X 的翻译通读,并恢复胱氨酸贮积症中的溶酶体胱氨酸外排。
PLoS One. 2019 Dec 4;14(12):e0223954. doi: 10.1371/journal.pone.0223954. eCollection 2019.
5
Impact of Cystinosin Glycosylation on Protein Stability by Differential Dynamic Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC).通过细胞培养中氨基酸的差异动态稳定同位素标记(SILAC)研究胱氨酸转运蛋白糖基化对蛋白质稳定性的影响。
Mol Cell Proteomics. 2017 Mar;16(3):457-468. doi: 10.1074/mcp.M116.063867. Epub 2017 Jan 12.
101例肾病型胱氨酸病患者的吞咽功能障碍:长期半胱胺治疗的益处
Medicine (Baltimore). 2005 May;84(3):137-146. doi: 10.1097/01.md.0000164204.00159.d4.
4
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.胱氨酸病的分子发病机制:CTNS 突变对胱氨酸转运体的转运活性及亚细胞定位的影响
Hum Mol Genet. 2004 Jul 1;13(13):1361-71. doi: 10.1093/hmg/ddh152. Epub 2004 May 5.
5
End-stage renal failure as manifestation of adolescent cystinosis.
Eur J Pediatr. 2004 Apr;163(4-5):260-1. doi: 10.1007/s00431-003-1395-4. Epub 2004 Feb 7.
6
Cystinosis.胱氨酸病
N Engl J Med. 2002 Jul 11;347(2):111-21. doi: 10.1056/NEJMra020552.
7
The molecular basis of Dutch infantile nephropathic cystinosis.荷兰婴儿型肾病性胱氨酸病的分子基础。
Nephron. 2001 Sep;89(1):50-5. doi: 10.1159/000046043.
8
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.胱氨酸病的表型严重程度因CTNS基因突变而异:对胱氨酸转运蛋白模型的预测影响。
Hum Mol Genet. 1999 Dec;8(13):2507-14. doi: 10.1093/hmg/8.13.2507.
9
Mutations of CTNS causing intermediate cystinosis.导致中间型胱氨酸病的CTNS基因突变。
Mol Genet Metab. 1999 Aug;67(4):283-93. doi: 10.1006/mgme.1999.2876.
10
CTNS mutations in an American-based population of cystinosis patients.美国胱氨酸病患者群体中的CTNS基因突变。
Am J Hum Genet. 1998 Nov;63(5):1352-62. doi: 10.1086/302118.